Epidemiology of Kala-Azar (Visceral Leishmaniasis) and Post-Kala-Azar Dermal Leishmaniasis in Bangladesh -A Prospective Cohort Study-

Epidemiology of Kala-Azar (Visceral Leishmaniasis) and Post-Kala-Azar Dermal Leishmaniasis in Bangladesh -A Prospective Cohort Study- - Epidemiology of Kala-Azar (Visceral Leishmaniasis) and Post-Kala-Azar Dermal Leishmaniasis in Bangladesh -A Prospective Cohort Study-

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011426

Enrollment

1000

Registered

2013-08-13

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kala-azar (visceral leishmaniasis) and post-kala-azar dermal leishmaniasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who visit the participating facilities and are diagnosed with kala-azar (visceral leishmaniasis) or post-kala-azar dermal leishmaniasis

Exclusion criteria

Exclusion criteria: Patients who refuse to participate in this observational study

Design outcomes

Primary

Measure	Time frame
Short- and long-term patient outcomes (1 month to 3 years) by treatment plan, especially the onset of post-kala-azar dermal leishmaniasis	—

Secondary

Measure	Time frame
1.Details of patient background, history, subjective symptoms, and objective findings at the time of diagnosis 2.Assessing the diagnostic effectiveness of serum and urine biomarkers	—

Countries

Asia(except Japan)

Contacts

Public ContactEisei Noiri

The University of Tokyo Hospital Department of Hemodialysis and Apheresis

noiri-tky@umin.ac.jp+81-3-3815-5411

Outcome results